Science Explorer Interactive view Map
Hospital / health system · Louisville · United States

Advanced Cancer Therapeutics

advancedcancertherapeutics.comROR OpenAlex
Research works
116
▼ 81% vs 2013–17
Citations
4.4k
38.0 per fractional work
Top-10% rate
31.8%
record average 16.5%
Open access
33%
world 28%

Not ranked overall: Advanced Cancer Therapeutics is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.60× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.89× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 11.56× its world share, 0 worksImmunology and Micro…Chemistry: 1.14× its world share, 0 worksChemistryEngineering: 0.47× its world share, 0 worksEngineeringMaterials Science: 1.14× its world share, 0 worksMaterials ScienceMedicine: 1.31× its world share, 1 worksMedicineBusiness, Management and Accounting: 1.67× its world share, 0 worksBusiness, Management…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.6×. Every wedge is a field page.

Which keywords describe research at Advanced Cancer Therapeutics?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Prognostic Factors, Targeted Therapy, Immunotherapy, Clinical Trials, Cancer Therapy, Genomic Profiling and ALK Inhibitors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy14▲ 17×17 topics
  2. Prognostic Factors9▲ 17×10 topics
  3. Targeted Therapy8▲ 33×5 topics
  4. Immunotherapy8▲ 10×14 topics
  5. Clinical Trials7▲ 9.6×9 topics
  6. Cancer Therapy7▲ 9.0×13 topics
  7. Cancer6▲ 3.6×28 topics
  8. Genomic Profiling5▲ 44×2 topics
  9. ALK Inhibitors5▲ 76×1 topic
  10. EGFR Mutations5▲ 76×1 topic
  11. Tumor Microenvironment5▲ 12×7 topics
  12. Rituximab5▲ 25×2 topics
  13. Prognosis4▲ 11×6 topics
  14. Genetic Mutations4▲ 6.6×7 topics
  15. Cetuximab4▲ 39×2 topics
  16. Breast Cancer4▲ 11×6 topics
  17. Clinical Practice Guidelines4▲ 5.5×7 topics
  18. Precision Medicine4▲ 10.0×4 topics
  19. Survival Analysis4▲ 11×6 topics
  20. Radiotherapy4▲ 8.0×7 topics
  21. Hematopoietic Stem Cells3▲ 29×3 topics
  22. Therapeutic Targets3▲ 12×4 topics
  23. PET Imaging3▲ 13×4 topics
  24. Regulation3▲ 4.6×7 topics
  25. Apoptosis3▲ 6.9×5 topics
  26. Mutation3▲ 18×2 topics
  27. Molecular Characterization3▲ 14×5 topics
  28. Tumor Suppression3▲ 23×3 topics
  29. BRAF Mutation3▲ 36×2 topics
  30. Molecular Subtypes3▲ 29×2 topics
  31. Chronic Lymphocytic Leukemia3▲ 52×1 topic
  32. Genomic Aberrations3▲ 52×1 topic
  33. Fluorouracil3▲ 73×1 topic
  34. KRAS Mutations3▲ 73×1 topic
  35. Nuclear Receptors3▲ 13×4 topics
  36. Lymphoma2▲ 15×3 topics
  37. Transcriptional Regulation2▲ 8.4×5 topics
  38. Cell Cycle2▲ 36×1 topic
  39. p532▲ 47×1 topic
  40. Signaling2▲ 17×4 topics

Which research topics does Advanced Cancer Therapeutics publish most on?

By volume in 2022–2025: HIV Research and Treatment, Accounting and Financial Management, Histone Deacetylase Inhibitors Research and Pluripotent Stem Cells Research.

HIV Research and Treatment: 0 fractional worksAccounting and Financial Management: 0 fractional worksHistone Deacetylase Inhi…0Histone Deacetylase Inhibitors Research: 0 fractional worksPluripotent Stem Cells R…0Pluripotent Stem Cells Research: 0 fractional works3D Printing in Biomedica…03D Printing in Biomedical Research: 0 fractional worksProtein Degradation and Inhibitors: 0 fractional worksRenal cell carcinoma treatment: 0 fractional worksBladder and Urothelial Cancer Treatments: 0 fractional worksGut microbiota and health: 0 fractional worksUrinary and Genital Oncology Studies: 0 fractional works
VirologyAccountingMolecular BiologyBiomedical Engineering2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 HIV Research and Treatment Virology 0 works
  2. 2 Accounting and Financial Management Accounting 0 works
  3. 3 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
  4. 4 Pluripotent Stem Cells Research Molecular Biology 0 works
  5. 5 3D Printing in Biomedical Research Biomedical Engineering 0 works
  6. 6 Protein Degradation and Inhibitors Molecular Biology 0 works
  7. 7 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works
  8. 8 Bladder and Urothelial Cancer Treatments Surgery 0 works
  9. 9 Gut microbiota and health Molecular Biology 0 works
  10. 10 Urinary and Genital Oncology Studies Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.1%not open66.9%

World: 28% of research is openly available.

with international co-authors22.9%domestic only77.1%

World: 19% is written across borders.

How has Advanced Cancer Therapeutics's research output changed?

Output in 2018–2022 was 81% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Louisville

All research institutions in Louisville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.